drug

acoramidis

1 story · latest Jul 2, 2026

Status: FDA approved Nov 2024 · NDA216540
Brands: Attruby, Beyonttra
Trials: 1 registered trial in coverage

Relationships

Developed by BridgeBio Pharma, Inc.

Also known as

acoramidis hydrochloride

Timeline

BridgeBio secures $1 billion preferred equity deal led by Sixth Street

Jul 2FinancingBridgeBio Pharma, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.